The 13 analysts offering 1 year price forecasts for KURA have a max estimate of — and a min estimate of —.
Analyst rating
Based on 15 analysts giving stock ratings to KURA in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
Be warned
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
KURA EPS for the last quarter is −0.63 USD despite the estimation of −0.63 USD. In the next quarter EPS is expected to reach −0.60 USD. Track more of Kura Oncology, Inc. financials and stay on top of what is up with the company.
In the next quarter Kura Oncology, Inc. revenue is expected to reach 5.50 M USD. Check out Kura Oncology, Inc. revenue and earnings and make informed decisions.
According to analysts, KURA price target is 30.08 USD with a max estimate of 37.00 USD and a min estimate of 18.00 USD. Check if this forecast comes true in a year, meanwhile watch Kura Oncology, Inc. stock price chart and keep track of the current situation with KURA news and stock market news.
We've gathered opinions of 15 analysts rating KURA stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.